Anhui Huaheng Biotechnology Co. Ltd. A (688639) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.004x

Based on the latest financial reports, Anhui Huaheng Biotechnology Co. Ltd. A (688639) has a cash flow conversion efficiency ratio of -0.004x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-10.19 Million ≈ $-1.49 Million USD) by net assets (CN¥2.63 Billion ≈ $385.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688639 company net worth for the company's overall valuation and market capitalisation.

Anhui Huaheng Biotechnology Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Anhui Huaheng Biotechnology Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Anhui Huaheng Biotechnology Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Anhui Huaheng Biotechnology Co. Ltd. A ranked by their cash flow conversion efficiency. Explore Anhui Huaheng Biotechnology Co. Ltd. A earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Catapult Group International Ltd
AU:CAT
0.334x
Nankang Rubber Tire Corp Ltd
TW:2101
0.166x
Weikeng Industrial Co Ltd
TW:3033
-0.355x
Linewell Software Co Ltd
SHG:603636
0.041x
Yunnan Tourism Co Ltd
SHE:002059
0.044x
Alpargatas S.A
SA:ALPA3
0.040x
Dexterra Group Inc
TO:DXT
0.148x
Beijing Electronic Zone Investment and Development Group Co Ltd
SHG:600658
0.024x

Annual Cash Flow Conversion Efficiency for Anhui Huaheng Biotechnology Co. Ltd. A (2012–2025)

The table below shows the annual cash flow conversion efficiency of Anhui Huaheng Biotechnology Co. Ltd. A from 2012 to 2025. View Anhui Huaheng Biotechnology Co. Ltd. A stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥2.63 Billion
≈ $385.12 Million
CN¥104.55 Million
≈ $15.30 Million
0.040x -49.13%
2024-12-31 CN¥2.56 Billion
≈ $374.37 Million
CN¥199.79 Million
≈ $29.24 Million
0.078x -53.14%
2023-12-31 CN¥1.83 Billion
≈ $267.15 Million
CN¥304.28 Million
≈ $44.53 Million
0.167x -30.91%
2022-12-31 CN¥1.48 Billion
≈ $216.81 Million
CN¥357.43 Million
≈ $52.30 Million
0.241x +198.23%
2021-12-31 CN¥1.18 Billion
≈ $173.13 Million
CN¥95.70 Million
≈ $14.00 Million
0.081x -63.84%
2020-12-31 CN¥489.78 Million
≈ $71.67 Million
CN¥109.57 Million
≈ $16.03 Million
0.224x -54.55%
2019-12-31 CN¥368.68 Million
≈ $53.95 Million
CN¥181.48 Million
≈ $26.56 Million
0.492x +71.02%
2018-12-31 CN¥310.29 Million
≈ $45.41 Million
CN¥89.31 Million
≈ $13.07 Million
0.288x -42.61%
2017-12-31 CN¥210.73 Million
≈ $30.84 Million
CN¥105.69 Million
≈ $15.47 Million
0.502x +60.67%
2016-12-31 CN¥176.26 Million
≈ $25.79 Million
CN¥55.02 Million
≈ $8.05 Million
0.312x +1.31%
2015-12-31 CN¥114.46 Million
≈ $16.75 Million
CN¥35.27 Million
≈ $5.16 Million
0.308x -45.45%
2014-12-31 CN¥54.10 Million
≈ $7.92 Million
CN¥30.56 Million
≈ $4.47 Million
0.565x -71.96%
2013-12-31 CN¥20.46 Million
≈ $2.99 Million
CN¥41.21 Million
≈ $6.03 Million
2.014x +332.61%
2012-12-31 CN¥7.80 Million
≈ $1.14 Million
CN¥-6.76 Million
≈ $-988.72K
-0.866x --

About Anhui Huaheng Biotechnology Co. Ltd. A

SHG:688639 China Biotechnology
Market Cap
$680.02 Million
CN¥4.65 Billion CNY
Market Cap Rank
#10889 Global
#3027 in China
Share Price
CN¥18.58
Change (1 day)
+2.09%
52-Week Range
CN¥15.40 - CN¥41.34
All Time High
CN¥85.44
About

Anhui Huaheng Biotechnology Co., Ltd. engages in the research and development, production, and sale of bio-based products through bio-manufacturing in China and internationally. The company offers amino acid products, including the alanine series, L-valine, isoleucine, tryptophan, and arginine; vitamin products, such as D-calcium pantothenate, D-panthenol, and inositol; bio-based new material mon… Read more